This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Denis Martin - Innovator in Medical Chemistry
Introduction
Denis Martin is a notable inventor based in Sainte-Geneviève-des-Bois, France. He has made significant contributions to the field of medical chemistry, particularly in the development of treatments for male reproductive health issues. His innovative work has led to the filing of a patent that addresses a critical medical condition.
Latest Patents
Denis Martin holds a patent for the "Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia." This patent highlights the use of a compound with the formula (I), which has the potential to improve the quality of life for individuals suffering from these conditions. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Denis Martin is associated with Sanofi-Synthelabo, a leading global healthcare company. His role at the company has allowed him to collaborate with other talented professionals in the field. His work is characterized by a commitment to innovation and a focus on developing effective medical solutions.
Collaborations
Throughout his career, Denis has worked alongside esteemed colleagues such as Sonia Arbilla and Itzchak Angel. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking medical treatments.
Conclusion
Denis Martin's contributions to medical chemistry exemplify the impact of innovation in healthcare. His patent for treating retrograde ejaculation and aspermia demonstrates his commitment to improving patient outcomes. Through his work at Sanofi-Synthelabo and collaborations with other professionals, he continues to make strides in the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
